Cure Research for Hypertrophic cardiomyopathy

Latest Treatments for Hypertrophic cardiomyopathy

Some of the more recent treatments for Hypertrophic cardiomyopathy include:

• Digoxin
• Furosemide
• Potassium chloride
• Captopril
• more treatments...»

Treatments for Hypertrophic cardiomyopathy

Treatments to consider for Hypertrophic cardiomyopathy may include:

• Lifestyle changes
• Medications
  • Beta blockers
  • Calcium channel blockers
  • Antiarrhythmic medications
  • Diuretics
• more treatments...»

Medical research for Hypertrophic cardiomyopathy: medical news summaries:

The following medical news items are relevant to medical research for Hypertrophic cardiomyopathy:

• Soy diet indicated in heart disease
• More news »

Hypertrophic cardiomyopathy Treatment: Book Excerpts

• Treatment - Asymmetric Limbs
• Treatment - Hypertrophic cardiomyopathy
• Treatment - Dilated cardiomyopathy
• Treatment - Restrictive cardiomyopathy
• Treatment - Septal perforation and deviation
• Treatment (Tx) - Ventricular aneurysm
• Treatment - Cardiomyopathy, hypertrophic
• Treatment - Cardiomyopathy, dilated
• Treatment - Cardiomyopathy, restrictive
• Treatment - aneurysm,ventricular

Clinical Trials for Hypertrophic cardiomyopathy

Some of the clinical trials for Hypertrophic cardiomyopathy include:

• Analysis of Heart Muscle Function in Patients With Heart Disease and Normal Volunteers - This study has been completed (Current: 23 Nov 2006)
• Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy - This study has been completed (Current: 23 Nov 2006)
• Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM) - This study has been completed (Current: 23 Nov 2006)
• Family Studies of Inherited Heart Disease - This study has been completed (Current: 23 Nov 2006)
• Long Term Effects of Enalapril and Losartan on Genetic Heart Disease - This study has been completed (Current: 23 Nov 2006) - Losartan
• more trials...»

Evidence Based Medicine Research for Hypertrophic cardiomyopathy

Medical research papers related to Hypertrophic cardiomyopathy include:

• To what extent is hypertrophic cardiomyopathy a concern with long term dothiepin? Is this a "class effect".
• Early (<
• Shared Genetic Causes of Cardiac Hypertrophy in Children and Adults.
• Differential diagnosis of chest pain.
• Outcomes in athletes with marked ECG repolarization abnormalities.
• Antibiotic prophylaxis for intrauterine contraceptive use in women at risk of bacterial endocarditis
• Does a family history of HOCM impact on a women (under 35) risk for taking COC
• Sudden Cardiac Arrest Associated with Early Repolarization.
• Antimicrobial prophylaxis against infective endocarditis
• Diagnosis and Treatment of Acute and Chronic Heart Failure
• Microvolt
• Does tricuspid regurgitation require the patient to have antibiotic prophylaxis before surgery?
• ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline
• Heart Failure Care
• Screening for hypertrophic cardiomyopathy
• Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy
• Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
• Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry.
• Alcohol septal ablation for obstructive hypertrophic cardiomyopathy Multiple choice questionnaire
• Hypertrophic Cardiomyopathy
• Apical Hypertrophic Cardiomyopathy
• Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0.
• Idebenone (SNT-MC17) Friedreich's ataxia
• Urgent surgery. In: I guidelines for perioperative evaluation.
• Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death.
• Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy.
• Prescribing amiodarone: an evidence-based review of clinical indications.
• Does a normal ECG rule out cardiomyopathy?
• The Athletic Preparticipation Evaluation: Cardiovascular Assessment
• Late gadolinium enhancement magnetic resonance imaging (LGE-MRI) Assessment of myocardial viability

Click here to find more evidence-based articles on the TRIP Database

 » Next page: Deaths from Hypertrophic cardiomyopathy

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

• Deaths from Hypertrophic cardiomyopathy
• Statistics about Hypertrophic cardiomyopathy
• Statistics by Country for Hypertrophic cardiomyopathy
• Medical News Summaries About Hypertrophic cardiomyopathy
• Hospital Statistics for Hypertrophic cardiomyopathy

Tools & Services:

• Bookmark this page
• Take a survey relating to Hypertrophic cardiomyopathy
• Symptom Search
• Symptom Checker
• Medical Dictionary
• Give your feedback

Medical Articles:

• Disease & Treatments Search
• Misdiagnosis Center
• Full list of interesting articles

Forums & Message Boards

• Ask or answer a question at the Boards:
• I cannot get a diagnosis. Please help.
• Tell us your medical story.
• Share your misdiagnosis story.
• What is the best treatment for my condition?
• See all the Boards.

Enter your search terms Submit search form
Search The Web Search wrongdiagnosis.com